Proprietary AI analyst is now available

Selvita Valuation Multiples

Discover Selvita's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Binex, Mycenax Biotech, Euroapi, Genovis and more.

Selvita Overview

About Selvita

Selvita SA is a Poland based parent company of Selvita Group is one of the largest preclinical contract research organizations in Europe. It also develops bioinformatics solutions supporting innovative projects at preclinical stages. It also provides services provided to external contractors are in the field of chemistry, analytics, regulatory, biochemistry and cell biology and also the integrated research and development projects.


Founded

2007

HQ

Poland

Employees

969

Financials (LTM)

Revenue: $102M
EBITDA: $19M

EV

$193M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Selvita Financials

Selvita reported last 12-month revenue of $102M and EBITDA of $19M.

In the same LTM period, Selvita generated $19M in EBITDA and $2M in net income.

Revenue (LTM)


Selvita P&L

In the most recent fiscal year, Selvita reported revenue of $100M and EBITDA of $19M.

Selvita is profitable as of last fiscal year, with gross margin of 79%, EBITDA margin of 19%, and net margin of 0%.

See analyst estimates for Selvita
LTMLast FY202320242025202620272028
Revenue$102M$100M$94M$92M$98M
Gross Profit-$79M$74M$72M$79M
Gross Margin-79%79%78%81%
EBITDA$19M$19M$34M$15M$17M
EBITDA Margin19%19%36%16%17%
EBIT Margin5%3%5%(0%)3%
Net Profit$2M$465K$19M($2M)$219K
Net Margin2%0%20%(2%)0%
Net Debt-$20M---

Financial data powered by Morningstar, Inc.

Selvita Stock Performance

Selvita has current market cap of $153M, and enterprise value of $193M.

Market Cap Evolution


Selvita's stock price is $8.33.

Selvita share price increased by 0.8% in the last 30 days, and by 1.8% in the last year.

Selvita has an EPS (earnings per share) of $0.03.

See more trading valuation data for Selvita
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$193M$153M0.0%0.8%-14.9%1.8%$0.03

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Selvita Valuation Multiples

Selvita trades at 1.9x EV/Revenue multiple, and 9.9x EV/EBITDA.

See NTM and 2027E valuation multiples for Selvita

EV / Revenue (LTM)


Selvita Financial Valuation Multiples

As of June 22, 2026, Selvita has market cap of $153M and EV of $193M.

Selvita has a P/E ratio of 82.2x.

LTMLast FY202320242025202620272028
EV/Revenue1.9x1.9x2.1x2.1x2.0x
EV/EBITDA9.9x10.4x5.8x12.9x11.4x
EV/EBIT40.7x57.0x42.7xn/m57.0x
EV/Gross Profit-2.4x2.6x2.7x2.4x
P/E82.2xn/m8.1x(93.0x)n/m
EV/FCF16.2x10.8x141.7x15.8x10.8x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Selvita Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Selvita Margins & Growth Rates

Selvita grew revenue by 3% and EBITDA by 10% in the last fiscal year.

In the most recent fiscal year, Selvita reported gross margin of 79%, EBITDA margin of 19%, and net margin of 0%.

See estimated margins and future growth rates for Selvita

Selvita Margins

Last FY202420252026202720282029
Gross Margin79%78%81%-
EBITDA Margin19%16%17%20%
EBIT Margin3%(0%)3%6%
Net Margin0%(2%)0%3%
FCF Margin18%13%18%10%

Selvita Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth3%(1%)6%5%
Gross Profit Growth-(3%)10%-
EBITDA Growth10%(56%)13%21%
EBIT Growth88%(103%)(2670%)88%
Net Profit Growth633%(109%)(113%)1454%
FCF Growth(41%)799%46%(41%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Selvita Operational KPIs

Selvita's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.

Selvita's Rule of 40 is 25% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Selvita's Rule of X is 33% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Selvita
LTMLast FY202320242025202620272028
Rule of 4025%25%---
Bessemer Rule of X34%33%---
Revenue per Employee-$0.1M---
Opex per Employee-$0.1M---
Opex to Revenue-76%75%78%77%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Selvita Competitors

Selvita competitors include Binex, Mycenax Biotech, Euroapi, Genovis, Savior Lifetec, Lifecore Biomedical, Prestige Biologics, Champions Oncology, Nanoform and J. Molner.

Most Selvita public comparables operate across Contract Research & Manufacturing, BioTech and DeepTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Binex1.9x1.8x25.9x77.5x
Mycenax Biotech8.2x-(44.5x)-
Euroapi0.1x0.1x1.0x1.1x
Genovis8.1x7.9x26.1x27.7x
Savior Lifetec4.0x-7.5x-
Lifecore Biomedical2.6x3.4x25.6x19.3x
Prestige Biologics17.9x-(39.7x)-
Champions Oncology1.5x-11.7x-

This data is available for Pro users. Sign up to see all Selvita competitors and their valuation data.

Start Free Trial

Acquisitions by Selvita

Selvita has acquired 1 company to date.

Last acquisition by Selvita was on March 27th 2024. Selvita acquired PozLab for $6M (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by Selvita

PozLab
Description
PozLab is a Poznań-based laboratory offering analytical and R&D services for pharmaceutical, food, cosmetic, and veterinary sectors in Poland. The firm develops formulations for drugs, dietary supplements, and cosmetics from initial concept through regulatory approval and market launch.
HQ CountryPoland
HQ City
Poznan
Deal Date27 Mar 2024
Valuation$6M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Selvita acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Selvita

When was Selvita founded?Selvita was founded in 2007.
Where is Selvita headquartered?Selvita is headquartered in Poland.
How many employees does Selvita have?As of today, Selvita has over 969 employees.
Is Selvita publicly listed?Yes, Selvita is a public company listed on Warsaw Stock Exchange.
What is the stock symbol of Selvita?Selvita trades under SLV ticker.
When did Selvita go public?Selvita went public in 2019.
Who are competitors of Selvita?Selvita main competitors include Binex, Mycenax Biotech, Euroapi, Genovis, Savior Lifetec, Lifecore Biomedical, Prestige Biologics, Champions Oncology, Nanoform, J. Molner.
What is the current market cap of Selvita?Selvita's current market cap is $153M.
What is the current revenue of Selvita?Selvita's last 12 months revenue is $102M.
What is the current revenue growth of Selvita?Selvita revenue growth (NTM/LTM) is 6%.
What is the current EV/Revenue multiple of Selvita?Current revenue multiple of Selvita is 1.9x.
What is the current EBITDA of Selvita?Selvita's last 12 months EBITDA is $19M.
What is Selvita's EBITDA margin?Selvita's last 12 months EBITDA margin is 19%.
What is the current EV/EBITDA multiple of Selvita?Current EBITDA multiple of Selvita is 9.9x.
What is the current FCF of Selvita?Selvita's last 12 months FCF is $12M.
What is Selvita's FCF margin?Selvita's last 12 months FCF margin is 12%.
What is the current EV/FCF multiple of Selvita?Current FCF multiple of Selvita is 16.2x.
How many companies Selvita has acquired to date?As of June 2026, Selvita has acquired 1 company.
What was the largest acquisition by Selvita?$6M acquisition of PozLab on 27th March 2024 was the largest M&A Selvita has done to date.
What companies Selvita acquired?Selvita acquired PozLab.
In how many companies Selvita has invested to date?Selvita hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Selvita

Lists including Selvita

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial